KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Gross Margin: 2011-2024

Historic Gross Margin for Pacira BioSciences (PCRX) over the last 14 years, with Dec 2024 value amounting to 75.69%.

  • Pacira BioSciences' Gross Margin rose 396.00% to 80.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.17%, marking a year-over-year increase of 481.00%. This contributed to the annual value of 75.69% for FY2024, which is 305.00% up from last year.
  • Latest data reveals that Pacira BioSciences reported Gross Margin of 75.69% as of FY2024, which was up 4.19% from 72.64% recorded in FY2023.
  • Pacira BioSciences' Gross Margin's 5-year high stood at 75.69% during FY2024, with a 5-year trough of 70.11% in FY2022.
  • Its 3-year average for Gross Margin is 72.81%, with a median of 72.64% in 2023.
  • In the last 5 years, Pacira BioSciences' Gross Margin slumped by 399bps in 2022 and then skyrocketed by 305bps in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' Gross Margin stood at 72.69% in 2020, then skyrocketed by 141bps to 74.10% in 2021, then slumped by 399bps to 70.11% in 2022, then skyrocketed by 253bps to 72.64% in 2023, then soared by 305bps to 75.69% in 2024.